Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.
about
Cardiac toxicity of trastuzumab in elderly patients with breast cancerNo Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry Data.The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.Trastuzumab in advanced breast cancer--a decade of experience in GermanyRisk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer.Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort.Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study.Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series
P2860
Q26741182-64FA9717-3A1C-48AF-8AB8-58569F0C94FFQ30977803-A5B60CCA-8D2A-438B-ACCA-0AE07F9FF350Q33573092-E439DD18-351D-4D9B-B751-4E64276847CDQ33682910-B344574C-B7EB-40A5-80BB-538A149D368BQ34969710-0F322F0D-10B7-4469-84EF-8BD6F3738DC3Q35880224-5E0A8DDE-C3D7-433A-A72D-70B5BB54D227Q37301426-41AB4A8E-D327-4D8E-841E-704E8BF11CE2Q37612139-3B9C9053-7FA8-4CCA-B33B-DBCEC8310360Q40892038-8A47BA24-6025-437F-9A79-3CBE5CDE95EFQ44806586-DA17E7F0-D7CE-47FE-A520-A52193C175B6Q47110699-62238519-F2D3-4556-B182-E47541C84450Q48243603-1E1E533C-EA49-41E8-8895-28E5CC120A1CQ50053475-EAFD09BB-777D-4C5A-B831-D4B4ED8964C9Q57815432-4DC69ADD-8BFF-44EB-9461-80F478B4E14E
P2860
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment patterns and clinica ...... registHER observational study.
@ast
Treatment patterns and clinica ...... registHER observational study.
@en
type
label
Treatment patterns and clinica ...... registHER observational study.
@ast
Treatment patterns and clinica ...... registHER observational study.
@en
prefLabel
Treatment patterns and clinica ...... registHER observational study.
@ast
Treatment patterns and clinica ...... registHER observational study.
@en
P2093
P2860
P1476
Treatment patterns and clinica ...... registHER observational study.
@en
P2093
Adam M Brufsky
Cheng S Quah
Debu Tripathy
Denise A Yardley
Hope S Rugo
Lisa I Wang
Marianne Ulcickas Yood
Musa Mayer
Peter A Kaufman
Shibao Feng
P2860
P2888
P304
P356
10.1007/S10549-012-2209-Z
P407
P577
2012-08-26T00:00:00Z